Anti-CD40 Agonist Monoclonal Antibody CDX-1140
I 1277721
Phase 2 mab active
Quick answer
Anti-CD40 Agonist Monoclonal Antibody CDX-1140 for Ovarian Clear Cell Adenocarcinoma is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Ovarian Clear Cell Adenocarcinoma
- Phase
- Phase 2
- Modality
- mab
- Status
- active